Post Herpetic Neuralgia Clinical Trial
Official title:
A Phase 4, Open Label, Study of Safety and Effectiveness of GRALISE™(Gabapentin) Tablets in the Treatment of Patients With Postherpetic Neuralgia in Clinical Practice
Verified date | March 2013 |
Source | Depomed |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Observational |
Study objective is to assess the safety and effectiveness of once- daily GRALISE in clinical practice
Status | Completed |
Enrollment | 201 |
Est. completion date | April 2012 |
Est. primary completion date | March 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Men or Women 18 years or older who are suffering from PHN Exclusion Criteria: - Patient is Pregnant or a nursing mother - Patient has hypersensitivity to gabapentin - Patient has an estimated creatinine clearance of <30 mL/min or is in hemodialysis |
Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Depomed |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change From Baseline to End of Study in LOCF VAS | Change from baseline in pain score on visual analog scale (VAS) (intensity scored from "No Pain" (0mm) to "Worst Possible Pain" (100mm)) at Week 8 of treatment; last observation carried forward (LOCF) analysis | 8 weeks (Baseline and Week 8) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT01124097 -
Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia
|
Phase 3 | |
Completed |
NCT03974438 -
Acupuncture as Treatment of Post-herpetic Neuralgia: A RCT A Double-blinded Randomized Clinical Trial.
|
N/A | |
Recruiting |
NCT04144972 -
Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain
|
N/A | |
Completed |
NCT03447756 -
Titration Study of ABX-1431
|
Phase 1 | |
Recruiting |
NCT06155487 -
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects
|
Phase 1 | |
Recruiting |
NCT06218784 -
A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.
|
Phase 1 | |
Completed |
NCT03584061 -
Treatment of Chronic Postherpetic Pain With Fat Grafting
|
N/A | |
Completed |
NCT01270828 -
Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia
|
Phase 3 | |
Enrolling by invitation |
NCT06410222 -
Predictive Models for the Treatment of Recurrent Herpes Zoster Neuralgia Following Spinal Cord Electrical Stimulation.
|
||
Recruiting |
NCT05754190 -
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
|
||
Completed |
NCT00475904 -
A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
|
Phase 2 | |
Completed |
NCT03765697 -
A Study With Lidocaine 5% Medicated Plaster in Patients Suffering From Postherpetic Neuralgia
|
Phase 3 | |
Not yet recruiting |
NCT06130514 -
The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Sympathetic Ganglion Block
|
N/A | |
Completed |
NCT01748877 -
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
|
Phase 2 | |
Active, not recruiting |
NCT06241820 -
The Success of Lumbar Sympathetic Ganglion Block Using Lower Extremity Perfusion Index
|
N/A | |
Completed |
NCT03745404 -
A Study With Lido-Patch and Placebo Plaster in Patients Suffering From Postherpetic Neuralgia (PHN)
|
Phase 3 |